Protalix BioTherapeutics Inc (PLX)
1.15
+0.01
(+0.88%)
USD |
NYAM |
Apr 17, 16:00
1.14
-0.01
(-0.87%)
Pre-Market: 20:00
Protalix BioTherapeutics Cash and Short Term Investments (Quarterly): 44.56M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.56M |
| September 30, 2023 | 40.98M |
| June 30, 2023 | 48.18M |
| March 31, 2023 | 33.04M |
| December 31, 2022 | 22.18M |
| September 30, 2022 | 20.81M |
| June 30, 2022 | 28.57M |
| March 31, 2022 | 32.92M |
| December 31, 2021 | 38.98M |
| September 30, 2021 | 48.66M |
| June 30, 2021 | 76.94M |
| March 31, 2021 | 70.43M |
| December 31, 2020 | 38.54M |
| September 30, 2020 | 41.29M |
| June 30, 2020 | 34.99M |
| March 31, 2020 | 36.68M |
| December 31, 2019 | 17.79M |
| September 30, 2019 | 21.44M |
| June 30, 2019 | 25.10M |
| March 31, 2019 | 30.36M |
| December 31, 2018 | 37.81M |
| September 30, 2018 | 41.87M |
| June 30, 2018 | 28.33M |
| March 31, 2018 | 41.32M |
| December 31, 2017 | 51.16M |
| Date | Value |
|---|---|
| September 30, 2017 | 33.48M |
| June 30, 2017 | 34.53M |
| March 31, 2017 | 48.02M |
| December 31, 2016 | 63.28M |
| September 30, 2016 | 51.32M |
| June 30, 2016 | 54.63M |
| March 31, 2016 | 66.67M |
| December 31, 2015 | 76.37M |
| September 30, 2015 | 34.25M |
| June 30, 2015 | 43.24M |
| March 31, 2015 | 47.96M |
| December 31, 2014 | 54.77M |
| September 30, 2014 | 60.32M |
| June 30, 2014 | 71.14M |
| March 31, 2014 | 77.69M |
| December 31, 2013 | 86.40M |
| September 30, 2013 | 91.40M |
| June 30, 2013 | 33.13M |
| March 31, 2013 | 41.87M |
| December 31, 2012 | 52.04M |
| September 30, 2012 | 50.22M |
| June 30, 2012 | 59.28M |
| March 31, 2012 | 45.60M |
| December 31, 2011 | 27.00M |
| September 30, 2011 | 34.56M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
17.79M
Minimum
Dec 2019
76.94M
Maximum
Jun 2021
38.00M
Average
36.68M
Median
Mar 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Agenus Inc | 76.11M |
| InfuSystems Holdings Inc | 0.231M |
| Corbus Pharmaceuticals Holdings Inc | 20.91M |
| AIM ImmunoTech Inc | 13.07M |
| Armata Pharmaceuticals Inc | 13.52M |